AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
AbCellera (Nasdaq: ABCL) executives to present at Bloom Burton Healthcare Conference. Live webcast and replay details provided.
03/19/2024 - 04:05 PM
VANCOUVER, British Columbia --(BUSINESS WIRE)--
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Bloom Burton Healthcare Conference on Tuesday, April 16, 2024, at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time).
A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website . A replay will be available through the same link following the presentation.
About AbCellera Biologics Inc .
AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240319507976/en/
Media: Kathleen Reid; media@abcellera.com , +1(236)521-6774
bd@abcellera.com , +1(604)559-9005
ir@abcellera.com , +1(778)729-9116
Source: AbCellera Biologics Inc.
When will AbCellera executives present at the Bloom Burton Healthcare Conference?
AbCellera executives will present at the Bloom Burton Healthcare Conference on Tuesday, April 16, 2024.
What is the ticker symbol for AbCellera?
The ticker symbol for AbCellera is ABCL.
Where can I access the live webcast of the presentation?
The live audio webcast of the presentation may be accessed through a link on AbCellera's Investor Relations website.
Will there be a replay available for the presentation?
Yes, a replay will be available through the same link following the presentation.
ABCL Rankings
#5068 Ranked by Stock Gains
ABCL Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Country
CA
City
Vancouver
About ABCL
abcellera is a canadian biotechnology company focused on accelerating the discovery of monoclonal antibody (mabs) therapeutics. antibodies are molecules that are naturally produced by the immune system of humans or animals to fight off infection and disease. the unique property of antibodies is that they can specifically recognize and target diseased cells or pathogens, making them precise and highly effective drugs with low side effects for the treatment of cancer, autoimmune disorders and infections. the immune system is capable of making billions to trillions of unique antibodies, each produced by a single immune cell. of these, only a select few are suitable for therapeutic applications. finding these rare antibodies presents a major roadblock in the development of new therapeutics. abcellera addresses this bottleneck by using microfluidic technology for the rapid and high-throughput analysis of antibodies directly from single cells. abcellera is a spinoff from dr. carl hansen’
